Pulmonary Delivery of Self-Amplifying RNA: Balancing Inflammation and Durable Transgene Expression
ACS Nano · 04.08.2026 · 20 (30) · 21022-21038
DOI: 10.1021/acsnano.6c00709 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 17.07.2026. Verfasst von Qing Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gene Therapy, Faculty of Veterinary Medicine, Ghent University, MerelbekeB-9820, Belgium. Hauptthemen laut MEDLINE: Lung, Transgenes, RNA, Messenger. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, China Scholarship Council, H2020 Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Self-amplifying mRNA (saRNA) is emerging as a leading platform for both vaccination and gene therapy. However, saRNA and the lipid nanoparticles (LNPs) used for their delivery activate the innate immune system, which may complicate pulmonary delivery of saRNA-LNPs. In this study, we demonstrated that intratracheal administration of saRNA-LNPs can cause significant side effects that can be linked to innate immune cell recruitment and cytokine release in the lungs. However, through systematic optimization of the LNP formulation and the saRNA dose, we could restrict the inflammation in the lungs to an acceptable level. With these optimized saRNA-LNPs, high levels of transgene expression were achieved in the lungs of mice that lasted for at least 21 days. Moreover, intratracheal delivery of optimized saRNA-LNPs encoding SARS-CoV-2 nanobodies resulted in detectable nanobody levels in the lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Gene Therapy, Faculty of Veterinary Medicine, Ghent University, MerelbekeB-9820, Belgium.
- Department of Internal Medicine, Reproduction and Population Health, Faculty of Veterinary Medicine, Ghent University, MerelbekeB-9820, Belgium.
- Institute for Laboratory Animal Science, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover30625, Germany.
- Cancer Research Institute (CRIG), Ghent University, Ghent9000, Belgium.
- Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, MerelbekeB-9820, Belgium.
ORCID-Profile: Qing Sun, Niek N Sanders
Förderung
- Fonds Wetenschappelijk Onderzoek
- China Scholarship Council
- H2020 Marie Sklodowska-Curie Actions
- Bijzonder Onderzoeksfonds
- Industrieel Onderzoeksfonds
Zitieren
APA
Sun, Q., Cui, X., Li, H., Vervaeke, P., Lienenklaus, S., Gillon, O., De Sutter, E., Helsmoortel, C., Devriendt, B., Snoeck, J., & Sanders, N. N. (2026). Pulmonary Delivery of Self-Amplifying RNA: Balancing Inflammation and Durable Transgene Expression. ACS Nano, 20(30), 21022-21038. https://doi.org/10.1021/acsnano.6c00709
Vancouver
Sun Q, Cui X, Li H, Vervaeke P, Lienenklaus S, Gillon O, et al. Pulmonary Delivery of Self-Amplifying RNA: Balancing Inflammation and Durable Transgene Expression. ACS Nano. 2026;20(30):21022-21038. doi:10.1021/acsnano.6c00709
BibTeX
@article{Sun2026,
author = {Sun, Qing and Cui, Xiaole and Li, Haitao and Vervaeke, Pieter and Lienenklaus, Stefan and Gillon, Oriane and De Sutter, Elisabeth and Helsmoortel, Charlotte and Devriendt, Bert and Snoeck, Janne and Sanders, Niek N},
title = {Pulmonary Delivery of Self-Amplifying RNA: Balancing Inflammation and Durable Transgene Expression},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {30},
pages = {21022--21038},
doi = {10.1021/acsnano.6c00709}
}
EUVIMED